PURE study may cause revision of fat intake guidelines for cardiology.

September 7, 2017 — Researchers at the European Society of Cardiology (ESC) Congress called for a reconsideration of global dietary guidelines in light of new late-breaking data presented from the Prospective Urban-Rural Epidemiology (PURE) on fat intake and cardiovascular risk and mortality. The study was presented at ESC and also published in the Lancet.

In July, The Heart Institute at Florida Medical Center became the first hospital in the state of Florida to offer the U.S. Food and Drug Administration (FDA)-cleared high sensitive Elecsys Troponin T Gen 5 blood test (Troponin T Gen 5 or TnT Gen 5) to aid in the diagnosis of heart attacks.  The new nine-minute test offers faster answers clinicians can use when diagnosing heart attack.

Protembis GmbH announced the first clinical applications of its ProtEmbo Cerebral Protection System to complement a transcatheter aortic valve replacement (TAVR) procedure. The ProtEmbo System is an intra-aortic filter device that deflects embolic material arising during TAVR away from the brain.

Echo for the Sonographer and Practitioner: Point-of-Care Ultrasound and Advanced Echo Tract

This is a Mayo Clinic CME course. For more information on Mayo cardiac courses go to https://cveducation.mayo.edu/store/

Basic to Advanced Echo

This is a Mayo Clinic CME course. For more information on Mayo cardiac courses go to https://cveducation.mayo.edu/store/

 

Echo Workshop at Vail

This is a Mayo Clinic CME course. For more information on Mayo cardiac courses go to https://cveducation.mayo.edu/store/

 

Cardiology at Cancun

This is a Mayo Clinic CME course. For more information on Mayo cardiac courses go to https://cveducation.mayo.edu/store/

 

Cardiology Update at Cabo: A Focus on Prevention

This is a Mayo Clinic CME course. For more information on Mayo cardiac courses go to https://cveducation.mayo.edu/store/

The U.S. Food and Drug Administration (FDA) has cleared TrueFusion, a new cardiovascular application from Siemens Healthineers that integrates ultrasound and angiography to guide cardiac teams when administering treatment for structural heart disease. Available on the new Release 5.0 of the Acuson SC2000 cardiovascular ultrasound system, TrueFusion is designed to maximize not only interventional cardiology procedures, but also routine diagnosis and follow-up of patients with structural heart disease.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now